RN Armor Vax Consortium Contract Details

Defense contract under the Defense Advanced Research Projects Agency awarded to RN Armor Vax Consortium on 9/23/2011.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.

Contractor: RN Armor Vax Consortium
Department: Defense Advanced Research Projects Agency
Awarded: 9/23/2011

The RN Armor Vax Consortium, Orlando, Fla., is being awarded a $17,300,230 technology investment agreement. The award is for a research and development program designed to identify, investigate, and develop candidate RNA vaccines against infectious disease. Work will be performed in Orlando, Fla. (19.59 percent); Lyon, France (11.93 percent); Tubingen, Germany (56.62 percent); and Nantes, France (11.86 percent). The work is expected to be completed by September 2015. The Defense Advanced Research Projects Agency is the contracting activity (HR0011-11-3-0001).

Total Contract Value: $17,300,230

View all contracts that include "RN Armor Vax Consortium" in the MiC database.